MedTrace Logo

Safety and Performance Evaluation of the Epitomee Device for Enhancing Satiety and Weight Loss.

NCT03610958 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2021-08-18

No results posted yet for this study

Summary

Study design to demonstrate the safety and performance of the Epitomee Device

Conditions

Interventions

DEVICE

Epitomee Device

A non-surgical, non-pharmacologic, medical Device designed to enhance the feeling of satiety.

Sponsors & Collaborators

  • Epitomee medical

    lead INDUSTRY

Principal Investigators

  • Haim Shirin, MD · The Kamila Gonczarowski Institute of Gastroenterology Assaf Harofeh Medical Center,

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-04
Primary Completion
2018-09-04
Completion
2018-09-04

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03610958 on ClinicalTrials.gov